CA3227681A1 - Method of treating posttraumatic stress disorder - Google Patents
Method of treating posttraumatic stress disorder Download PDFInfo
- Publication number
- CA3227681A1 CA3227681A1 CA3227681A CA3227681A CA3227681A1 CA 3227681 A1 CA3227681 A1 CA 3227681A1 CA 3227681 A CA3227681 A CA 3227681A CA 3227681 A CA3227681 A CA 3227681A CA 3227681 A1 CA3227681 A1 CA 3227681A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- individual
- treatment
- dosage form
- oral dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163229387P | 2021-08-04 | 2021-08-04 | |
| US63/229,387 | 2021-08-04 | ||
| PCT/US2022/074469 WO2023015206A1 (en) | 2021-08-04 | 2022-08-03 | Method of treating posttraumatic stress disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3227681A1 true CA3227681A1 (en) | 2023-02-09 |
Family
ID=83149040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3227681A Pending CA3227681A1 (en) | 2021-08-04 | 2022-08-03 | Method of treating posttraumatic stress disorder |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240335441A1 (https=) |
| EP (1) | EP4380571A1 (https=) |
| JP (1) | JP2024529022A (https=) |
| KR (1) | KR20240046737A (https=) |
| CN (1) | CN118284419A (https=) |
| AU (1) | AU2022323513A1 (https=) |
| CA (1) | CA3227681A1 (https=) |
| MX (1) | MX2024001673A (https=) |
| TW (1) | TW202320779A (https=) |
| WO (1) | WO2023015206A1 (https=) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602007011793D1 (de) * | 2006-10-18 | 2011-02-17 | Pfizer Prod Inc | Biaryl-ether-harnstoffverbindungen |
-
2022
- 2022-08-03 CA CA3227681A patent/CA3227681A1/en active Pending
- 2022-08-03 JP JP2024506897A patent/JP2024529022A/ja active Pending
- 2022-08-03 AU AU2022323513A patent/AU2022323513A1/en active Pending
- 2022-08-03 EP EP22761888.1A patent/EP4380571A1/en active Pending
- 2022-08-03 CN CN202280058527.2A patent/CN118284419A/zh active Pending
- 2022-08-03 US US18/294,129 patent/US20240335441A1/en active Pending
- 2022-08-03 KR KR1020247007299A patent/KR20240046737A/ko active Pending
- 2022-08-03 WO PCT/US2022/074469 patent/WO2023015206A1/en not_active Ceased
- 2022-08-03 MX MX2024001673A patent/MX2024001673A/es unknown
- 2022-08-03 TW TW111129103A patent/TW202320779A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023015206A1 (en) | 2023-02-09 |
| JP2024529022A (ja) | 2024-08-01 |
| MX2024001673A (es) | 2024-04-30 |
| TW202320779A (zh) | 2023-06-01 |
| CN118284419A (zh) | 2024-07-02 |
| AU2022323513A1 (en) | 2024-02-22 |
| KR20240046737A (ko) | 2024-04-09 |
| US20240335441A1 (en) | 2024-10-10 |
| EP4380571A1 (en) | 2024-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220226262A1 (en) | Methods of treating doose syndrome using fenfluramine | |
| US20230093150A1 (en) | Changing cognitive function with fenfluramine | |
| AU2016312526B2 (en) | Methods of treating lennox-gastaut syndrome using fenfluramine | |
| McConnell et al. | Comorbidity in Epilepsy | |
| US20210299064A1 (en) | Method of treating patients with lennox-gastaut syndrome | |
| Hendershot et al. | Application of an alcohol clamp paradigm to examine inhibitory control, subjective responses, and acute tolerance in late adolescence. | |
| US20090054414A1 (en) | Rufinamide for the Treatment of Post-Traumatic Stress Disorder | |
| US20100069402A1 (en) | Treatment of Behavioral Disorders | |
| JP2023509720A (ja) | 認知障害の予防及び療法 | |
| JP2010534674A (ja) | 心的外傷後ストレス障害の治療用４−ヒドロキシ−４−メチル−ピペリジン−１−カルボン酸（４−メトキシ−７−モルホリン−４−イル−ベンゾチアゾール−２−イル）−アミド | |
| Roth et al. | Efficacy and safety of doxepin 6 mg in a model of transient insomnia | |
| DeVito et al. | Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects | |
| US20240335441A1 (en) | Method of treating posttraumatic stress disorder | |
| Middelboe et al. | Psychiatric sequelae of minor head injury. A prospective follow-up study | |
| Ozyurt et al. | Investigating the potential link between bruxism and obsessive-compulsive symptomatology: An exploratory study | |
| Baggott et al. | 3, 4-Methylenedioxymethamphetamine (MDMA): A review of the English-language scientific and medical literature | |
| Rintakoski | Sleep bruxism–genetic factors and psychoactive substances | |
| Praveen | A Comparative Study to Evaluate the Efficacy and Safety of Levetiracetam as Add-On to Carbamazepine and Phenytoin in Focal Seizures at a Tertiary Care Hospital | |
| Dousset et al. | The impact of anti-craving medication on cue reactivity and abstinence in patients undergoing alcohol detoxification: some preliminary evidence from a retrospective event-related potentials study | |
| Truong | SUBSTANCE USE AND HIV | |
| WO2026022492A1 (en) | Nitroxoline for use in the treatment and/or prevention of pain | |
| Broadstock et al. | The effectiveness of pharmacological therapies for young people and adults with Autism Spectrum Disorder (ASD) | |
| INSTRUMENTS | Psychometric Assessment of Anxiety | |
| Brierley-Bowers | Child and Adolescent Program of the 41st Annual National Institute of Mental Health (NIMH) New Clinical Drug Evaluation Unit (NCDEU) Meeting, Phoenix, Arizona, May 28–31, 2001 | |
| Denney | Characterization and Differences Between Possible and Probable Mild Cognitive Impairment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250702 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250702 |